Executive Summary

Oct 2019
PROSPECTS
Pollution, climate change and ageing population key growth drivers

Pollution and global warming is likely to call for an increased demand of certain dermatologicals. Due to longer and warmer days, the number of patients suffering from sun-related allergies will likely increase.

Growing awareness of the efficacy of antipruritics boosts demand

Eczema and dry skin are relatively common in Norway, as the cold and harsh winters generally make the skin dryer. The use of heating has a further negative impact on the skin.

Hair-related dermatologicals losing foothold as consumers turn to alternatives

Medicated shampoos and hair loss treatments will be obstacles to higher growth in dermatologicals in the forecast period, as these categories are projected to struggle for significant growth. Medicated shampoos is expected to continue its decline in current value terms, with this being due to the substitution effect from products such as premium shampoos and specialised mass shampoos, including professional brands sold in hair salons.

COMPETITIVE LANDSCAPE
Canoderm continues to support the rapid rise of ACO Hud Norge

ACO Hud Norge extended its lead in dermatologicals in 2019, largely due to the strong growth of its antipruritics brand Canoderm. The upswing of this brand was due to its enhanced brand image based on favourable research and increased brand recognition through its availability on a “blue prescription” since 2016, with its value sales doubling following this move.

Bayer remains in second place due to lack of presence in antipruritics

Despite losing the lead to ACO Hud Norge earlier in the review period, Bayer AS nevertheless retained a strong value share in 2019 with continuing to see modest growth. The overall declining interest in antifungals saw the company’s largest brand Canesten lose further value share in 2019.

Well-known brands retain the trust of consumers creating a barrier to entry

The top-ranked brands tend to drive sales in dermatologicals, as consumers are reluctant to try out new or lesser-known brands. The brand ranking within each product category therefore often remains rather fixed, as Norwegians are usually reluctant to try out unrecognised brands, as they are uncertain of the quality of these compared with brands they recognise.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Dermatologicals in Norway

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Norway with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Norway, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Norway market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Norway?
  • What are the major brands in Norway?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Dermatologicals in Norway - Category analysis

HEADLINES

PROSPECTS

Pollution, climate change and ageing population key growth drivers
Growing awareness of the efficacy of antipruritics boosts demand
Hair-related dermatologicals losing foothold as consumers turn to alternatives

COMPETITIVE LANDSCAPE

Canoderm continues to support the rapid rise of ACO Hud Norge
Bayer remains in second place due to lack of presence in antipruritics
Well-known brands retain the trust of consumers creating a barrier to entry

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2014-2019
Table 2 Sales of Dermatologicals by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Dermatologicals: % Value 2015-2019
Table 4 LBN Brand Shares of Dermatologicals: % Value 2016-2019
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2016-2019
Table 6 Forecast Sales of Dermatologicals by Category: Value 2019-2024
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024

Consumer Health in Norway - Industry Overview

EXECUTIVE SUMMARY

Consumer health sees steady growth as Norwegians show willingness to invest in health
Changing face of Norway sees shifts in demand within consumer health
GlaxoSmithKline and Pfizer combine to push GSK Consumer Healthcare into the lead
Distribution focuses on convenience, quality and availability
An ageing population, a greater focus on health and wellbeing and climate change just some of the issues expected to drive growth over the forecast period

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 9 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2014-2019
Table 11 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 12 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 13 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format: % Value 2014-2019
Table 16 Distribution of Consumer Health by Format and Category: % Value 2019
Table 17 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources